Cees J van Echteld
Overview
Explore the profile of Cees J van Echteld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Te Boekhorst B, van t Klooster R, Bovens S, Van De Kolk K, Cramer M, van Oosterhout M, et al.
Magn Reson Med
. 2011 Oct;
67(6):1764-75.
PMID: 21997890
Intra-plaque hemorrhage (IPH) and lipid core, characteristics of rupture prone carotid plaques, are often visualized in vivo with MRI using T1 weighted gradient and spin echo, respectively. Increasing magnetic field...
2.
Te Boekhorst B, Bovens S, Hellings W, van der Kraak P, Van De Kolk K, Vink A, et al.
Cardiovasc Res
. 2010 Oct;
89(3):680-8.
PMID: 21030534
Aims: Neutrophil gelatinase-associated lipocalin (NGAL) is an effector molecule of the innate immune system. One of its actions is the prolongation of matrix metalloproteinase-9 (MMP-9) activity by the formation of...
3.
van Laake L, Passier R, den Ouden K, Schreurs C, Monshouwer-Kloots J, Ward-van Oostwaard D, et al.
Stem Cell Res
. 2009 Jun;
3(2-3):106-12.
PMID: 19560991
Transplantation of human embryonic stem cell-derived cardiomyocytes (hESC-CM) has been shown to improve the function of the rodent heart 1 month after myocardial infarction (MI). However, the mechanistic basis and...
4.
Smits A, van Laake L, den Ouden K, Schreurs C, Szuhai K, van Echteld C, et al.
Cardiovasc Res
. 2009 May;
83(3):527-35.
PMID: 19429921
Aims: Recent clinical studies revealed that positive results of cell transplantation on cardiac function are limited to the short- and mid-term restoration phase following myocardial infarction (MI), emphasizing the need...
5.
van Laake L, Passier R, Monshouwer-Kloots J, Verkleij A, Lips D, Freund C, et al.
Stem Cell Res
. 2009 Apr;
1(1):9-24.
PMID: 19383383
Regeneration of the myocardium by transplantation of cardiomyocytes is an emerging therapeutic strategy. Human embryonic stem cells (HESC) form cardiomyocytes readily but until recently at low efficiency, so that preclinical...
6.
van Laake L, Passier R, Monshouwer-Kloots J, Nederhoff M, Ward-van Oostwaard D, Field L, et al.
Nat Protoc
. 2007 Oct;
2(10):2551-67.
PMID: 17947998
We have developed a mouse severe combined immunodeficient (SCID) model of myocardial infarction based on permanent coronary artery occlusion that allows long-term functional analysis of engrafted human embryonic stem cell-derived...